Company: IPGP
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001111928-25-000132
Chunk: 8

Company: IPG PHOTONICS CORP
Filing Date: 2025-08-05
Form: 10-Q
Item: Part II, Item 1A
Chunk 8
---
 2025, a total of 14,532 shares were withheld to cover at an average price of $65.01. 

(2)  On February 13, 2024, we announced that our Board of Directors authorized the purchase of up to $300 million of IPG common stock (the "February 2024 authorization"), exclusive of any fees, commissions or other expenses. Share repurchases under these purchase authorization were made periodically in open-market transactions using our working capital, and were subject to market conditions, legal requirements and other factors. The share purchase program authorizations did not obligate us to repurchase any dollar amount or number of our shares, and repurchases could be commenced or suspended from time to time without prior notice. 

We repurchased 490,982 shares in the second quarter of 2025 under the February 2024 authorization.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

29

Table of Contents

ITEM 5. OTHER INFORMATION

During the Registrant's last fiscal quarter ended June 30, 2025, the following director and executive officers of the Registrant adopted Rule 10b5-1 trading arrangements:

•on May 28, 2025, Mr. Trevor Ness, Senior Vice President, Sales and Strategic Business Development of the Registrant, adopted a Rule 10b5-1 trading arrangement for the sale of up to 6,715 shares over a period beginning August 18, 2025 and ending February 17, 2026 on the open market at prevailing prices, subject to minimum price thresholds; and

•on June 13, 2025, Dr. Eugene Scherbakov, Director of the Registrant, and Mr. Angelo P. Lopresti, Senior Vice President, General Counsel and Corporate Secretary of the Registrant, adopted a joint Rule 10b5-1 trading arrangement with the following trusts (of which Dr. Scherbakov and Mr. Lopresti are trustees): the Valentin Gapontsev Trust I, the Valentin Gapontsev Trust II, the Valentin Gapontsev Trust III and a related company, IP Fibre Devices (UK) Limited. The arrangement allows for the sale of up to 16,000 shares by Dr. Scherbakov and up to 6,000 shares by Mr. Lopresti, over a period beginning September